This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Authentidate Holding Corp. Reports Fiscal 2013 Second Quarter Results

Stocks in this article: ADAT

BERKELEY HEIGHTS, N.J., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based software applications and telehealth products and services for healthcare organizations, today announced financial results for the three and six month periods ended December 31, 2012.

Selected highlights for the second quarter include:

  • Increased revenues for the quarter by approximately 59% compared to the same period in the prior year, reflecting growth from both our telehealth products and services and our hosted software services.
  • Completed the required test-in phase with the Department of Veterans Affairs (VA) for our Interactive Voice Response (IVR) vital signs monitoring solution for use with the VA's weight management protocol (TeleMOVE) and the VA approved the use of the IVR solution for TeleMove by VA facilities throughout the country.
  • Announced the addition of NBN Group as a new customer for our Inscrybe® Referral Management solution.
  • Added Charles C. Lucas III to our board of directors and expanded the size of the board to six members. Mr. Lucas is currently the general counsel of Elevation LLC, an institutional broker-dealer, and is active in numerous civic and philanthropic organizations, including serving as a Trustee of The Duke Endowment and as Chairman of the Board of Trustees of the University of North Carolina School of the Arts.

Following the end of the quarter, the company announced that it had completed the integration and required testing of the interface between its telehealth solutions and the VA's VistA Electronic Health Records system and that the VA had approved the interface for use in its national telehealth program. The interface to VistA is designed to make it faster and easier for clinicians to enroll patients, manage patient care plans and update patient information in the VistA system. The company also announced that the VA had approved a number of new Disease Management Protocols (DMPs) over the past few months for both of our telehealth solutions which continues to make these solutions available to a larger patient population at the VA. As part of our focus on expanding our addressable markets, the company announced its plans to introduce a mobile telehealth tablet and a telehealth software application in February 2013 to complement our present telehealth products and services and provide for a broader range of price points and patient segments that can benefit from telehealth. The new products are designed to address the growing need for mobility in the telehealth marketplace as well as the needs of healthcare providers looking for ways to reduce patient care costs and the high hospital readmission rate of patients with chronic illnesses. In connection with our expense and cash management activities, the company changed its compensation modification program to further reduce employee compensation, converted all director compensation to non-cash equity based grants and reduced certain other operating expenses beginning in January 2013.

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs